Zynex, Inc. (ZYXI) to Offer Common Stock
Tweet
Share
E-mailGet Alerts ZYXI Hot Sheet
Join SI Premium – FREE
Zynex, Inc. (Nasdaq: ZYXI) announced today that it is commencing an underwritten public offering of shares of its common stock. Zynex and certain of its stockholders are proposing to sell shares of its common stock in the proposed offering. In addition, Zynex and the selling stockholders intend to grant the underwriters a 30-day option to purchase additional shares of its common stock at the public offering price, less the underwriting discounts and commissions. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
Zynex intends to use the net proceeds from this proposed offering to expand its sales force and marketing activities, launch its blood volume monitor, as well as for working capital and other general corporate purposes, including potential corporate, business or market development activities. Zynex will not receive any proceeds from the sale of the shares by the selling stockholders in the proposed offering.
Piper Sandler & Co. is acting as sole book-running manager of the proposed offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- enVVeno Medical (NVNO) files $100M mixed shelf
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
S3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
